Claims
- 1. A compound of the formula ##STR14## wherein A is ##STR15## X being hydrogen, halogen, methyl, methoxy or hydroxyl, halogen being fluorine, chlorine, bromine or iodine; and R is ethyoxycarbonyl, cyanoloweralkyl, phenylcarbonylloweralkyl, phenoxyloweralkyl, phenylacetyl or cycloalkylcarbonyl where the carbonyl group of the phenylcarbonylloweralkyl may be in the ethylene ketal form; and the phenyl or phenoxy group in said phenylcarbonyloweralkyl, phenoxyloweralkyl or phenylacetyl group may have a halogen attached thereto and a pharmaceutically acceptable acid addition salt of any of the foregoing.
- 2. A compound as defined in claim 1 wherein R is ethoxycarbonyl.
- 3. A compound as defined in claim 1 wherein R is cyclopropylcarbonyl.
- 4. A compound as defined in claim 1 wherein R is phenylacetyl.
- 5. A compound as defined in claim 1 wherein R is 3-phenoxypropyl.
- 6. A compound as defined in claim 1 wherein R is cyanomethyl.
- 7. A compound as defined in claim 1 wherein R is 3-(4-fluorobenzoyl)propyl.
- 8. A compound as defined in claim 1 wherein R is 2-cyanoethyl.
- 9. The compound as defined in claim 1 which is cis-2-ethoxycarbonyl-1,2,3,4,4a,9b-hexahydro-4a-phenyl-benzofuro[3,2-c]pyridine or a pharmaceutically acceptable salt thereof.
- 10. The compound as defined in claim 1 which is cis-2-cyclopropylcarbonyl-1,2,3,4,4a,9b-hexahydro-4a-phenyl-benzofuro[3,2-c]pyridine or a pharmaceutically acceptable salt thereof.
- 11. The compound as defined in claim 1 which is cis-1,2,3,4,4a,9b-hexahydro-4a-phenyl-2-phenylacetyl-benzofuro[3,2-c]pyridine or a pharmaceutically acceptable salt thereof.
- 12. The compound as defined in claim 1 which is cis-1,2,3,4,4a,9b-hexahydro-2-(3-phenoxypropyl)-4a-phenyl-benzofuro[3,2-c]pyridine or a pharmaceutically acceptable salt thereof.
- 13. The compound as defined in claim 1 which is cis-2-cyanomethyl-1,2,3,4,4a,9b-hexahydro-4a-phenyl-benzofuro[3,2-c]pyridine or a pharmaceutically acceptable salt thereof.
- 14. The compound as defined in claim 1 which is cis-2-[3-(4-fluorobenzoyl)-propyl]-1,2,3,4,4a,9b-hexahydro-4a-phenyl-benzofuro[3,2-c]pyridine ethylene ketal or a pharmaceutically acceptable salt thereof.
- 15. The compound as defined in claim 1 which is cis-2-[3-(4-fluorobenzoyl)-propyl]-1,2,3,4,4a,9b-hexahydro-4a-phenyl-benzofuro[3,2-c]pyridine or a pharmaceutically acceptable salt thereof.
- 16. The compound as defined in claim 1 which is cis-2-(2-cyanoethyl)-1,2,3,4,4a,9b-hexahydro-4a-phenyl-benzofuro[3,2-c]pyridine or a pharmaceutically acceptable salt thereof.
Parent Case Info
This is a division, of application Ser. No. 400,576 filed July 22, 1982, now U.S. Pat. No. 4,507,306.
Foreign Referenced Citations (1)
Number |
Date |
Country |
51-23519 |
Jul 1976 |
JPX |
Non-Patent Literature Citations (1)
Entry |
Synthesis of Benzofuro[3,2-e][1,4]Diazepine, Settimj et al., Chem. Abstracts 100:103303p. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
400576 |
Jul 1982 |
|